Octreide acetate hmoov tsis muaj No.83150-76-9

Octreide acetate hmoov tsis muaj No.83150-76-9

Khoom npe: Octrtetreide acetate hmoov
Yam khoom Source: Chemically synthesized (artificially synthesized somatostatin analog)
Cov ntsiab lus Specifications: Kev Txhaj Tshuaj: 0.05mg / 1ML, 0.1MG / 1ML / 1MG / 1ML, 0.5mg, 0.5mg / 1mg / 5ml; Mear ustained - Tso Tawm Npaj: 10mg, 20mg, 30Mg / Lub raj mis
Tus lej lej: 83150-76-9
Kev Nrhiav Kom Paub: HPLC
Nquag xyaw: Octreotide acetate
Cov yam ntxwv khoom: Dawb rau tawm tawm - nkauj lyophilized los yog txhawb nqa - tso cov duab npaj
Cov khoom siv siv: 1. Kev kho mob ntawm lub npe hluav taws xob;
2. Cov tsos mob tswj ntawm cov qog nqaij hlav neuroendocrine;
3. Mobsute hemostasis rau ESOPHAGAL thiab PASTRIC VARICEAll OL;
4. Kev kho kom zoo ntawm pancreatic fistula thiab plab hnyuv.
Cov Khoom Muag Khoom Ntim: Ua Tub Yees ntawm 2-8 Degree, tiv thaiv los ntawm Lub Teeb (Unpoorened)
Txee Lub Neej: 24-36 hlis (tsis tuaj yeem siv, lub sijhawm tshwj xeeb raws li tau qhia rau ntawm kev ntim khoom)
Xa kev nug

Cov khoom lag luam

modular-1
Xi'an Tihealth High - purity octreotide acetate hmoov

Tihealth adopts an international standard production system to ensure stable product purity>99.5% (HPLC Nrhiav tau), endotoxin<5EU/mg, and moisture content<5.0%. Our freeze-dried powder formulation has excellent batch stability and solubility, strictly meeting various standard requirements. The product can meet the full cycle needs of pharmaceutical companies from raw material application to commercial production. With strict quality control and flexible supply chain. Tikangyuan will provide you with a stable supply service of Octreotide Acetate Powder raw materials

 

KhoomRooj mov

Octreide Acetate Hmoov yog ib qho synthesially synthesized somatostatin analog

 

✅ txuag kev txwv ntawm ntau qhov kev ua haujlwm loj thiab cov tshuaj laus (xws li cov hormones loj hlob, insulin, glucagon, astrin, thiab lwm yam)

✅ Kev tswj cov kev tso tawm VASOactive cov tshuaj (xws li serotonin thiab vasoative plab hnyuv vip)

✅ inhibit patholit pathological cell proliferation (qee cov qog nqaij qog nqaij hlav)

 

Nco tseg:Cov khoom siv raw nws tus kheej tsis ncaj qha tsim cov kev ua tau zoo thiab yuav tsum tau ua rau kev tsim tawm cov nyhuv.

Mechanism ntawm Kev Ua

Ua lub luag haujlwm los ntawm xaiv los ntawm kev sib txuas nrog Somatostatin receptor (sstr2 / sstr6 subtype):

 

Inhibit hormone zais ntshis:Thaiv Adenylate Cyclase, txo qib pw hav zoov, thiab txo qis cov tshuaj tawm;

 

Inhibiting cell proliferation:Ua kom tyrosine phosphatase thiab thaiv kev loj hlob ntawm txoj kev teeb tsa;

 

Txo cov ntshav visceral:Cog lus rau cov leeg nqaij du ntawm cov kab mob visceral, txo cov portal leeg ntshav ntws (yuam sij rau hemostasis).

KhoomTsis xaiv

Raws li ib qho khoom siv ua tshuaj, nws yog tsuas yog siv rau hauv kev tsim cov khoom siv hauv qab no

 

Intravenous / subcutaneess txhaj tshuaj:

-} pa taws ayopageal- pais}}}}}} pa taws voliceal los ntawm daim siab cirrhosis (qis portrhosis (qis portrhost)

- Cov tsos mob tswj hwm ntawm lub plab zom mov thiab pancreatic neuroendocrine hlav (xws li Carcinnor Syndrome, Vipoma)

- Adjuvant kev kho mob tom qab kev phais mob lossis phais hluav taws xob rau cov acromegaly (qis dua gh thiab iGF-1 qib)

 

Ntev - ua yeeb yam -} tso tawm cov tsom iav:

-} Txi} -}}}}}}}}}}}}}}}}}}}}}}

Pharmacological cuam tshuam

Cov mobileological los ntawm Octreotide acetate hmoov suav nrog:

-}}}}}}} inovion ntawm cov tshuaj hormones xws li cov tshuaj loj hlob, glucagon, insulin, thiab lwm yam.

-}}} Txo cov ntshav visceral thiab inhibit lub zais pa taws hauv plab hnyuv (GEP) endocrine.

{{0-} promote promotealis Txhawb Bile excretion thiab txhim kho cov kab mob kev sim siab.

{{0- los ntawm Inhibiting Pancantic zais cia, txo cov kev tso zais ntawm cov zom zom zom mov thiab bicarbonate, raws plab tuaj yeem tswj hwm.

- txo cov ntshav siab porperion, ua rau lub txaj visceral roob vascular, thiab txo cov ntshav venous ntshav ntws.

Cov yam ntxwv tseem ceeb ntawm cov khoom xyaw ua tshuaj

-- High purity ensures activity:>99.5% Purity (HPLC) Ua kom cov neeg tau txais kev txhim kho tau zoo

 

- Tsawg kawg endotoxin tswj:<5 EU/mg, meeting the safety requirements for injections

 

- Batch Stability: Strict Kub thiab Vaum Tswj, Txee Lub Neej Txog rau 24 Lub Hlis

Cim npe nrov: Octreide acetate hmoov tsis muaj ua hauj lwm No.83150-76-9, Tuam Tshoj Octrteide acetate Hmoov xyev Cas No.83150-76-9 Cov Chaw Tsim Tshuaj, Chaw Tsim Tshuaj

Xa kev nug